TET2 was identified as a tumor suppressor and mutations across the gene have been implicated in acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and myelodysplastic syndrome (MDS) [68]. This evidence concerns the gene TET2 and myelodysplastic syndrome.